SCHEMBL23798024

SCHEMBL23798024

CC(C)[C@@H]1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12039702 1.00
SCHEMBL25905313 1.00
Hydrochloric Acid SCHEMBL20744136 0.97
Hydrochloric Acid SCHEMBL38658242 0.97
Hydrochloric Acid SCHEMBL38657598 0.97
SCHEMBL1104709 0.85
SCHEMBL489437 0.85
SCHEMBL4762840 0.85
Hydrochloric Acid SCHEMBL1317388 0.83
Hydrochloric Acid SCHEMBL25314974 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802121-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2023-10-31 US disclosed
US-20230242552-A1 Nitrogen-Containing Heterocyclic Compound, Preparation Method Therefor and Use Thereof 280 Bio, Inc (US) 2023-08-03 US disclosed
US-20230124938-A1 GLP-1 RECEPTOR AGONISTS AND USES THEREOF PFIZER INC. (US) 2023-04-20 US disclosed
WO-2021178920-A1 COMPOUNDS FOR TARGETED DEGRADATION OF BRD9 C4 THERAPEUTICS, INC. (US) 2021-09-10 WO disclosed